CINCINNATI,
July 23,
2024 /PRNewswire/ -- The life science division of
Meridian Bioscience, Inc., a leading global provider of diagnostic
testing solutions and life science raw materials, announces its
comprehensive suite of eco-conscious, cost-effective innovations
tailored for diagnostic assay developers. Committed to advancing
the sustainability goals of the in vitro Diagnostics (IVD)
industry, Meridian has developed cutting-edge solutions that
minimize waste, enhance efficiency, and broaden accessibility
across molecular and immunoassays.
As a premier supplier of essential raw
materials for the IVD industry, we believe that sustainability
begins with us.
As diagnostic manufacturers face increasing
pressure to integrate Environmental, Social, and Governance (ESG)
sustainability into their operations, innovative solutions in raw
materials and reagents are essential for reducing the carbon
footprint of diagnostic assays.1 In response, Meridian
has curated a comprehensive portfolio of eco-conscious and
cost-efficient solutions designed to meet specific challenges
like:
- Overcoming Cold Chain Logistics Barriers: Meridian's
glycerol-free, high-concentration molecular reagents and services
enable the development of ambient-temperature stable assays,
eliminating the need for cold chain logistics and ensuring robust
and seamless supply chains. This reduces energy consumption
in transit and storage as well as minimizes packaging requirements,
particularly the use of refrigerant, dry ice, and expanded
polystyrene foam (Styrofoamâ„¢).
- Streamlining Workflows: Meridian's extraction-free,
low-temperature molecular solutions streamline workflows by
eliminating the need for multiple reagent-based extraction steps
and reducing the overall energy consumption required for
high-temperature processes. Streamlined workflows with fewer steps
result in faster turnaround times and increased throughput,
reducing operational energy and resource use.
- Providing Animal-Free Alternatives: Reagents generated
using animal immunization present scientific and ethical concerns.
Meridian's animal-free recombinant alternatives for immunoassays
(blockers, antibodies, and antigens) can offer greater versatility
and reproducibility over animal immunization, ensuring continuity
of supply while alleviating ethical concerns.
"As a premier supplier of essential raw materials
for molecular and immunoassays, we believe that sustainability in
the IVD industry begins with us," said Lourdes Weltzien, Ph.D., President of Life
Science at Meridian Bioscience. "Our innovative solutions are
aligned with multiple United Nations (UN) Sustainable Development
Goals. By leveraging these advancements, we enable our customers to
achieve their sustainability goals, bolster their competitive edge,
and realize significant improvements in operational efficiency and
cost savings."
Meridian's product development strategy is
centered on creating sustainable, cost-effective solutions. A
robust lineup of product launches is planned for the latter half of
2024 and will continue well into 2025 and beyond. Meridian's
innovations enhance efficiency across supply chain and workflow
processes, improve accessibility, and increase customers'
competitive advantage. Partnering with Meridian supports IVD
manufacturers in further enhancing their diagnostics operations
while continuing to contribute to a more ethical and sustainable
future.
The Meridian Bioscience Life Science team will
showcase its innovative sustainability solutions for IVD
manufacturers at the upcoming Association for Diagnostics &
Laboratory Medicine (ADLM) annual meeting, which will be held in
Chicago from July 28 to August 1, 2024. Join us at the
McCormick Place Convention Center in booth #3516.
For more information about Meridian's
sustainability solutions, please
visit https://www.meridianbioscience.com/sustainable-innovation
About Meridian Bioscience,
Inc.
Meridian is a fully integrated life science
company that develops, manufactures, markets, and distributes a
broad range of innovative diagnostic and life science products. We
are dedicated to developing and delivering better solutions that
give answers with speed, accuracy, and simplicity that are
redefining the possibilities of life from discovery to diagnosis.
Through discovery and development, we provide critical life science
raw materials used in immunological and molecular tests for human,
animal, plant, and environmental applications. Through diagnosis,
we provide diagnostic solutions in areas including gastrointestinal
and upper respiratory infections and blood lead level testing. We
build relationships and provide solutions to hospitals, reference
laboratories, research centers, veterinary testing centers,
physician offices, diagnostics manufacturers, and biotech companies
in more than 70 countries around the world. Meridian is a privately
held company headquartered in Cincinnati, Ohio. Meridian's website
address is www.meridianbioscience.com.
Reference:
1.
|
Ji, L., Wang, Y., Xie,
Y., Xu, M., Cai, Y., Fu, S., Ma, L., & Su, X. (2022). Potential
life-cycle environmental impacts of the COVID-19 nucleic acid test.
Environmental Science & Technology, 56(18), 13398-13407.
https://doi.org/10.1021/acs.est.2c04039
|
Contact:
Courtney Schulz
Director of Digital and Corporate Communications
Meridian Bioscience, Inc.
Phone: 513.271.3700
Email: mbi@meridianbioscience.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/meridian-bioscience-leads-the-way-with-innovative-sustainable-solutions-for-in-vitro-diagnostic-manufacturers-302196026.html
SOURCE Meridian Bioscience, Inc.